Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) Statistically significant and clinically ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

DELRAY BEACH, Fla., Nov. 11, 2024 /PRNewswire/ -- The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6% ...

The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to IO102-IO103. KEYTRUDA® is ...

The price of ethereum, or 1 ETH, was $2,633.95 as of 8 a.m. ET. The crypto’s highest intraday price in the past year was ...

Placed second of five finalists for Merck KGaA's EMEA Advance Biotech Grant which celebrates ... For more information, please visit Theriva Biologics' website at www.therivabio.com.

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...

A giant letter "L" was installed in the Lindsay Heights neighborhood on Tuesday, Nov. 12. It's one of six WaterMarkers in the city of Milwaukee. WaterMarkers show an illuminated blue letter, chosen b ...

The City of Sheboygan says it is actively working to respond to and investigate a network issue on Sunday, Nov. 10, that resulted in a demand for a ransom. In a statement, city lead ...

Award recipients to receive in-kind technologies and services to accelerate therapeutics to market Merck experts to provide consultation and training in qualification, risk assessment, and process ...